Gaelle Fossard Selected Research

Cyclophosphamide (Cytoxan)

1/2024

Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gaelle Fossard Research Topics

Disease

2	Neoplasms (Cancer) 01/2018 - 01/2015
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024
1	VEXAS syndrome 01/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018
1	Infections 01/2015
1	Neoplasm Metastasis (Metastasis) 01/2015
1	Lung Neoplasms (Lung Cancer) 01/2015

Drug/Important Bio-Agent (IBA)

1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024
1	Janus Kinase InhibitorsIBA 01/2022
1	ruxolitinibIBA 01/2022
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	ProcalcitoninIBA 01/2015

Therapy/Procedure

1	Transplantation 01/2024
1	Hematopoietic Stem Cell Transplantation 01/2024
1	Therapeutics 01/2018